Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_assertion type Assertion NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_head.
- NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_assertion description "[Plasma Chr-A was 34 +/- 10 in parathyroid adenoma, 55 +/- 33 in parathyroid hyperplasia without FMEN1, 63 +/- 88 in FMEN1, and 25 +/- 8 in controls (mean +/- SD; nanograms per ml; FMEN1 or parathyroid hyperplasia vs. control, P less than 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_provenance.
- NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_assertion evidence source_evidence_literature NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_provenance.
- NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_assertion SIO_000772 2571619 NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_provenance.
- NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_assertion wasDerivedFrom befree-20140225 NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_provenance.
- NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_assertion wasGeneratedBy ECO_0000203 NP306013.RA0Z_KPjY-YkH44dixhejLkN4e3HBbKVCwep7TvX56_88130_provenance.